Firstly, we have shown that norepinephrine suppresses IL-17 and IFN-γ production by activated CD4+ T cells and PBMCs (Figure 1), which corresponds to our previous data and confirms the anti-inflammatory effect of norepinephrine on Th17 cells in MS and EAE [10,11]. This evidence concerns the gene IL17A and myeloid sarcoma.